Piyawat Nandeenopparit / Shutterstock.com
11 October 2019Big PharmaSaman Javed
Fed Circuit rules against Actavis knee pain generic
Actavis Laboratories cannot market a generic version of Horizon Pharma’s knee pain treatment, an appeals court has ruled.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
15 May 2017 Ireland-based Horizon Pharma has filed a complaint against Actavis for patent infringement.
Editor's picks
Editor's picks
Americas
15 May 2017 Ireland-based Horizon Pharma has filed a complaint against Actavis for patent infringement.
Americas
15 May 2017 Ireland-based Horizon Pharma has filed a complaint against Actavis for patent infringement.